Evidera
Dimitra Lambrelli has extensive work experience in the field of health economics and research. Dimitra has held senior roles at Evidera since 2014, including Senior Director and Senior Research Scientist in Real World Evidence. Prior to that, they worked at UnitedBioSource as a Senior Research Associate. Dimitra also has experience as a Health Economist at the National Health Service-Economic Evaluation Database and the National Collaborating Centre for Mental Health. Dimitra has worked as a consultant at Innovatia Ltd. and Euroconsultants S.A & Innotatia Ltd. Dimitra's earlier experience includes working as a Health Economist at NICE, where they conducted economic evaluations for national clinical guidelines. Their expertise lies in database analytics, real-world evidence, and health economic modeling.
Dimitra Lambrelli has a diverse educational background. From 2004 to 2009, they pursued a Phd in Health Economics at the University of Macedonia, Economic and Social Sciences-Department of Economics. Prior to that, they attended the London School of Hygiene and Tropical Medicine, U. of London from 2001 to 2002, where they obtained a Master of Science degree in Health Services Management. From 1991 to 2001, Dimitra studied Pharmacy at Aristotle University of Thessaloniki (AUTH), earning a Bachelor's degree. Additionally, they have taken various courses to enhance their expertise, such as a Doctoral Course in Advanced Modelling Methods for Health Economic Evaluation at the University of York in 2003, a PhD Training Course in Health Econometrics at the University of Bergen (UiB) in 2005, and pursued further studies in Health Economics and Econometrics at the University of York in 2006.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.